Glycine, tablets 100 mg, 50 pcs.

Glycine is a metabolic drug.

Glycine is a metabolic regulator, normalizes and activates the processes of protective inhibition in the CNS, reduces psycho-emotional stress, increases mental performance. Glycine has glycine and GABA-ergic, alpha 1-adrenoblocking, antioxidant, antitoxic effects, regulates the activity of glutamate (NMDA) receptors, due to which the drug is able to

• reduce psychoemotional tension, aggressiveness, conflict, increase social adaptation;
• improve mood;

.

• Ease falling asleep and normalize sleep
• increase mental performance
• reduce vascular disorders (including depression).
• reduce the severity of cerebral disorders in ischemic stroke and brain injury
• reduce the toxic effects of alcohol and other drugs that depress CNS function.

Pharmacokinetics

Easy penetration into most body fluids and tissues including brain; it is metabolized to water and carbon dioxide and does not accumulate in tissues.

Indications

reduced mental performance;
stressful situations – psycho-emotional stress (during exams, conflict situations, etc.);
deviant forms of behavior of children and adolescents;
various functional and organic diseases of the nervous system accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbances: neuroses, neurosis-like states and vegetative-vascular dystonia, consequences of neuroinfections and traumatic brain injury, perinatal and other forms of encephalopathies (including alcoholic origin);
ischemic stroke.

Pharmacological effect

Glycine is a metabolic drug.

Glycine is a metabolic regulator, normalizes and activates protective inhibition processes in the central nervous system, reduces psycho-emotional stress, and increases mental performance. Glycine has glycine- and GABA-ergic, alpha1-adrenergic blocking, antioxidant, antitoxic effects; regulates the activity of glutamate (NMDA) receptors, due to which the drug is able to:

reduce psycho-emotional stress, aggressiveness, conflict, increase social adaptation;
improve mood;
make it easier to fall asleep and normalize sleep;
increase mental performance;
reduce vegetative-vascular disorders (including during menopause);
reduce the severity of brain disorders in ischemic stroke and traumatic brain injury;
reduce the toxic effect of alcohol and other drugs that depress the function of the central nervous system.

Pharmacokinetics

Easily penetrates into most biological fluids and tissues of the body, incl. into the brain; metabolized to water and carbon dioxide, its accumulation in tissues does not occur.

Active ingredient

Glycine

Composition

Active ingredient:

glycine;

Excipients:

microcrystalline cellulose,

povidone (polyvinylpyrrolidone),

magnesium stearate

Contraindications

Individual hypersensitivity to the components of the drug.

Interaction

Reduces the severity of side effects of antipsychotics (neuroleptics), anxiolytics, antidepressants, hypnotics and anticonvulsants.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 °C.

Shelf life

3 years

Manufacturer

Moskhimfarmpreparaty, Russia